✦ LIBER ✦

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

✍ Scribed by Esteva, F.J.

Book ID: 122004556
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 53 KB
Volume: 21
Category: Article
ISSN: 1043-321X
DOI: 10.1016/j.breastdis.2010.10.054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FemZone trial: a randomized phase II tri

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

✍ Fasching, Peter A; Jud, Sebastian M; Hauschild, Maik; Kümmel, Sherko; Schütte, M 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 251 KB

A phase II parallel group study with let

A phase II parallel group study with letrozole plus goserelin in premenopausal, and letrozole in postmenopausal metastatic breast cancer patients as first line hormone therapy

✍ J. Ro; K.S. Lee; H. Han; E. Lee; H.S. Kang; S.W. Kim; Y. Kwon; B. Nam 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

5048 A Q-TWiST analysis of lapatinib plu

5048 A Q-TWiST analysis of lapatinib plus letrozole compared with letrozole alone as first-line therapy in hormone receptor positive (HR+) metastatic breast cancer (MBC)

✍ B. Sherrill; M. Amonkar; B. Sherif; J. Maltzman; L. O'Rourke; S. Johnston 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Letrozole Versus Letrozole plus Lapatini

Letrozole Versus Letrozole plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized, Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB)

✍ Antonio Frassoldati; Valentina Guarneri; Federico Piacentini; Gordana Jovic; Sim 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 88 KB

Randomized phase II study of lapatinib p

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases

✍ Nancy U. Lin; Wolfgang Eierman; Richard Greil; Mario Campone; Bella Kaufman; Kla 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 189 KB

Double-Blind, Placebo-Controlled, Multic

Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase IIB Neoadjuvant Study of Letrozole-Lapatinib in Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Operable Breast Cancer

✍ Guarneri, V.; Generali, D. G.; Frassoldati, A.; Artioli, F.; Boni, C.; Cavanna, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 157 KB